Prof. Jin Wu 吴瑾
Chief Physician, Professor
Department of Medical Oncology (II), Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Symptomatic support for advanced cancer, anemia, metastases, and chemotherapy side effects. Neoadjuvant and adjuvant chemotherapy. Individualized treatment for liver, biliary, pancreatic, head and neck, melanoma, renal, and bladder cancers, with a focus on elderly patients.
Dr. Wu is Chief Physician, Professor, and Director of the Seventh Internal Medicine Department at Harbin Medical University Cancer Hospital. Holding a medical doctorate, Dr. Wu has practiced since 1987, focusing on chemotherapy, immunotherapy, targeted therapy, and integrative medicine for various malignancies. Research interests include early diagnosis of digestive tract tumors and metastasis markers.
Professional roles
- Standing Committee Member, Geriatric Oncology Professional Committee, Chinese Geriatrics Society
- Chair, Geriatric Oncology Professional Committee, Heilongjiang Geriatrics Society
- Standing Committee Member, Chemotherapy Professional Committee, Heilongjiang Anti-Cancer Association
- Standing Committee Member, Chinese Society of Clinical Oncology (CSCO)
Name order: in Chinese the family name comes first (Wu Jin). Papers usually list the name as Jin Wu or Wu J.
Selected publications
19 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Apoptosis, 2025 (senior author): Targeting BACH1 by HPPE inhibits the Wnt/β-catenin pathway and malignant phenotype in glioblastoma cells. PubMed 40956552
- J Cancer, 2024 (senior author): METTL3 Inhibition Suppresses Cell Growth and Survival in Colorectal Cancer via ASNS Downregulation. PubMed 39132158
- J Ethnopharmacol, 2024 (senior author): The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: Ixeris sonchifolia Induces Hepatocellular Carcinoma Apoptosis via the PI3K/AKT Pathway. PubMed 38437889
- Biosci Rep, 2020 (senior author): NR2F2-AS1 accelerates cell proliferation through regulating miR-4429/MBD1 axis in cervical cancer. PubMed 32469064
- J Cell Physiol, 2019 (senior author): Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p to facilitate the malignancy of ovarian cancer. PubMed 30537154
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion